|
WO1989008661A1
(en)
|
1988-03-18 |
1989-09-21 |
The General Hospital Corporation |
Human heat shock factor
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
DK0700445T3
(da)
|
1993-06-04 |
2002-05-13 |
Whitehead Biomedical Inst |
Stressproteiner og anvendelser deraf
|
|
DK0751957T3
(da)
|
1994-03-21 |
2004-06-01 |
Univ Utrecht |
Peptid-fragmenter af mikrobielle stressproteiner og farmaceutisk sammensætning fremstillet deraf til behandling og forebyggelse af inflammatoriske sygdomme
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
HU222994B1
(hu)
*
|
1995-11-02 |
2004-01-28 |
BIOREX Kutató és Fejlesztő Rt. |
Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
IN183280B
(hu)
|
1996-09-20 |
1999-10-30 |
Univ New Mexico |
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
CZ20002669A3
(cs)
|
1998-01-23 |
2001-11-14 |
National Jewish Medical And Research Center |
Pouľití proteinů tepelného ąoku nebo molekuly nukleové kyseliny, která jej kóduje, přípravek tyto látky obsahující, způsob výběru léčby přecitlivělosti nebo nedostatečnosti průchodu dýchacích cest
|
|
EP2295065B1
(en)
|
1998-02-20 |
2013-10-09 |
The University of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
JP4832640B2
(ja)
|
1998-03-27 |
2011-12-07 |
ガブリエル ミュルソフ |
Ｈｓｐ７０タンパク質の新規使用
|
|
FR2777890B1
(fr)
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6274597B1
(en)
|
1998-06-01 |
2001-08-14 |
Mount Sinai School Of Medicine Of New York University |
Method of enhancing lysosomal α-Galactosidase A
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
HU226617B1
(en)
|
1998-12-14 |
2009-04-28 |
Cytrx Corp |
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
|
|
HUP9900475D0
(en)
|
1999-02-26 |
1999-04-28 |
Biorex Kutato Fejlesztoe Kft |
O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
|
|
EP1218030A4
(en)
|
1999-09-10 |
2004-09-15 |
Univ Fordham |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF GRAFT REJECTS USING THERMAL SHOCK PROTEINS
|
|
US20020039583A1
(en)
|
1999-09-30 |
2002-04-04 |
Subjeck John R. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US20030236300A1
(en)
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
AU1582801A
(en)
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US6964851B2
(en)
|
1999-12-07 |
2005-11-15 |
Stressgen Biotechnologies Corp. |
Compositions and methods for detecting stress-inducible proteins
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
AU2001229597A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Compositions and methods to treat neurodegenerative disorders
|
|
AU2001227960A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
|
|
HUP0001583A2
(hu)
|
2000-04-18 |
2002-11-28 |
BIOREX Kutató és Fejlesztő Rt. |
Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
|
|
WO2001097829A2
(en)
|
2000-06-19 |
2001-12-27 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020037290A1
(en)
|
2000-08-07 |
2002-03-28 |
Armen Garo H. |
Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof
|
|
ES2326114T3
(es)
|
2000-09-13 |
2009-10-01 |
Multimmune Gmbh |
Un peptido de hsp70 estimulador de la actividad de las celulas asesinas naturales (nk) y los usos del mismo.
|
|
CA2422867A1
(en)
|
2000-09-15 |
2002-04-25 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
WO2002041921A2
(en)
|
2000-11-03 |
2002-05-30 |
The Board Of Regents Of The University Of Nebraska |
Compositions for protection against bovine viral diseases
|
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
|
US20020142299A1
(en)
|
2001-01-09 |
2002-10-03 |
Davidson Beverly L. |
PTD-modified proteins
|
|
WO2002065989A2
(en)
|
2001-02-20 |
2002-08-29 |
Uab Research Foundation |
Aminoglycoside treatment for lysosomal storage diseases
|
|
EP1536829A4
(en)
|
2001-08-20 |
2006-05-31 |
Univ Connecticut Health Ct |
METHOD FOR PRODUCING COMPOSITIONS WITH HEAT SHOCK PROTEINS OR ALPHA-2-MACROGLOBULIN FOR THE TREATMENT OF CANCER AND INFECTION DISEASES
|
|
HU0103939D0
(en)
|
2001-09-27 |
2001-11-28 |
Biorex Kutato Fejlesztoe Kft |
Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
|
|
CA2461254A1
(en)
|
2001-09-27 |
2003-04-10 |
I.D.M. Immuno-Designed Molecules |
Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
ITMI20012573A1
(it)
|
2001-12-06 |
2003-06-06 |
D B P Dev Biotechonologica L P |
Gli acilsalicilati:una nuova classe di induttori di risposta heat shock
|
|
US7384936B2
(en)
|
2002-01-11 |
2008-06-10 |
Cytrx Corporation |
Carboxamidine derivatives and their use in the treatment of vascular diseases
|
|
WO2003061684A2
(en)
|
2002-01-24 |
2003-07-31 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Tumour treatment compositions comprising hsp70 and tumour necrosis factor
|
|
WO2003068941A2
(en)
|
2002-02-13 |
2003-08-21 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
IL148401A0
(en)
|
2002-02-26 |
2002-09-12 |
Hadasit Med Res Service |
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
|
|
WO2003086452A2
(en)
|
2002-04-05 |
2003-10-23 |
Genzyme Corporation |
Methods of enhancing lysosomal storage disease therapy
|
|
CA2483449A1
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
RU2375077C2
(ru)
|
2002-05-02 |
2009-12-10 |
Юниверсити Оф Коннектикут Хелт Сентер |
Использование белков теплового шока для повышения эффективности терапий антителами
|
|
JP2006507272A
(ja)
|
2002-05-02 |
2006-03-02 |
ユニバーシティー オブ コネティカット ヘルス センター |
熱ショックタンパク質−ペプチド複合体またはα−２−マクログロブリン−ペプチド複合体を含むワクチンに対する免疫応答を増強するための熱ショックタンパク質およびα−２−マクログロブリンの使用
|
|
GB0216414D0
(en)
|
2002-07-15 |
2002-08-21 |
Novartis Ag |
Organic compounds
|
|
JP2006515165A
(ja)
|
2002-09-16 |
2006-05-25 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための新規組成物と方法
|
|
ES2396231T3
(es)
|
2003-05-21 |
2013-02-20 |
Biotech Tools S.A. |
Complejo peptídico
|
|
US7244616B2
(en)
|
2003-06-27 |
2007-07-17 |
Bayer Pharmaceuticals Corporation |
Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
|
|
HUP0303584A3
(en)
*
|
2003-10-30 |
2009-12-28 |
Cytrx Corp |
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
|
|
EP2145896A3
(en)
|
2003-11-12 |
2010-03-31 |
Alfa Biogene International B.V. |
Recovery of a heat shock protein
|
|
EP1691819A4
(en)
|
2003-11-25 |
2009-05-06 |
Sinai School Medicine |
THERAPY ON CHAPERON BASIS FOR NIEMANN PICK DISEASE
|
|
ES2324538T3
(es)
|
2003-12-05 |
2009-08-10 |
Multimmune Gmbh |
Anticuerpos anti-hsp terapeuticos y de diagnostico.
|
|
US20060009520A1
(en)
|
2004-05-12 |
2006-01-12 |
Tall Alan R |
Retinoid-based methods for altering macrophage cholesterol
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
AU2005312415B2
(en)
|
2004-12-10 |
2012-02-02 |
Angteq B.V. |
Heat shock proteins (HSP) and supraventricular arrhythmia
|
|
KR20080033242A
(ko)
|
2005-06-08 |
2008-04-16 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
리소좀 효소를 코딩하는 유전자의 돌연변이와 관련있는ｃｎｓ 질환의 치료 방법
|
|
WO2007041285A2
(en)
|
2005-09-29 |
2007-04-12 |
Viral Genetics, Inc. |
Complexes of inactivated pepsin fraction and heat shock protein
|
|
SI2395002T1
(sl)
|
2005-11-08 |
2014-10-30 |
Vertex Pharmaceuticals Incorporated |
Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
|
|
US20080039400A1
(en)
|
2006-01-24 |
2008-02-14 |
Universiteit Utrecht Uu Holding B.V. |
Treatment and prevention of inflammatory bowel diseases
|
|
AU2007210159A1
(en)
|
2006-01-26 |
2007-08-09 |
Foldrx Pharmaceuticals, Inc. |
Compounds and methods for modulating protein trafficking
|
|
WO2007137239A2
(en)
|
2006-05-19 |
2007-11-29 |
The Scripps Research Institute |
Treatment of protein misfolding
|
|
KR101402554B1
(ko)
|
2006-06-23 |
2014-06-19 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
β-글루코세레브로시다제의 활성 증진에 의한 신경계 장애 치료 방법
|
|
JP5599610B2
(ja)
|
2006-06-30 |
2014-10-01 |
スローン − ケッタリング インスティチュート フォー キャンサー リサーチ |
Ｈｓｐ９０の阻害による神経変性疾患の処置
|
|
WO2008021210A2
(en)
|
2006-08-11 |
2008-02-21 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
EP2057195A4
(en)
|
2006-08-29 |
2010-05-12 |
Forhumantech Co Ltd |
PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME
|
|
TW200831479A
(en)
*
|
2006-09-26 |
2008-08-01 |
Cytrx Corp |
Pharmaceutical compositions and methods for treating diseases
|
|
WO2008070010A2
(en)
|
2006-12-01 |
2008-06-12 |
Cytrx Corporation |
Hydroxylamine derivatives for the treatment of stroke
|
|
EP2132309A4
(en)
|
2007-02-23 |
2011-01-05 |
Univ Florida |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES RELATED TO GLYCOGEN STORAGE
|
|
EP2155197A4
(en)
|
2007-03-09 |
2011-10-12 |
Link Medicine Corp |
TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
GB0705626D0
(en)
|
2007-03-23 |
2007-05-02 |
Royal Veterinary College |
Method for enhancing sperm survival
|
|
WO2008127680A2
(en)
|
2007-04-11 |
2008-10-23 |
The Jackson Laboratory |
Diagnosis and treatment of diseases caused by misfolded proteins
|
|
MX2009011055A
(es)
|
2007-04-13 |
2010-01-13 |
Amicus Therapeutics Inc |
Tratamiento de la enfermedad de gaucher con chaperonas farmacologicas especificas y supervision del tratamiento utilizando marcadores sustitutos.
|
|
DK2481400T3
(da)
|
2007-04-25 |
2014-09-29 |
Opko Ip Holdings Ii Inc |
Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
|
|
US9056101B2
(en)
|
2007-04-26 |
2015-06-16 |
Amicus Therapeutics, Inc. |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
|
|
TW200901958A
(en)
|
2007-05-04 |
2009-01-16 |
Cytrx Corp |
Diabetic wound healing
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
|
US8742068B2
(en)
|
2007-07-06 |
2014-06-03 |
Universiteit Utrecht Holding B.V. |
Treatment and prevention of inflammatory diseases and autoimmune diseases
|
|
WO2009036349A1
(en)
|
2007-09-12 |
2009-03-19 |
Anaphore, Inc. |
Hsp70-based treatment for autoimmune diseases
|
|
EP2252288A1
(en)
|
2007-11-21 |
2010-11-24 |
Summit Corporation Plc |
Treatment of protein folding disorders
|
|
GB2466912B
(en)
|
2007-11-29 |
2012-01-04 |
Hospital For Sick Children |
Compositions and methods for treating lysosomal disorders
|
|
ATE555191T1
(de)
|
2008-01-30 |
2012-05-15 |
Geron Corp |
Synthetische oberflächen zur kultivierung von zellen in chemisch definierten medien
|
|
WO2009095452A1
(en)
|
2008-01-31 |
2009-08-06 |
Crystax Pharmaceuticals, S.L. |
Crystal structure of the atpase domain of proteins of the hsp70 family
|
|
CA2712593A1
(en)
|
2008-02-01 |
2009-08-13 |
The Scripps Research Institute |
Methods for treating a condition characterized by dysfunction in protein homeostasis
|
|
EP3778652A1
(en)
|
2008-05-07 |
2021-02-17 |
BioMarin Pharmaceutical Inc. |
Lysosomal targeting peptides and uses thereof
|
|
WO2009137796A2
(en)
|
2008-05-08 |
2009-11-12 |
Northwestern University |
Method of regulating the heat shock response
|
|
GB0809360D0
(en)
|
2008-05-22 |
2008-07-02 |
Isis Innovation |
Calcium modulation
|
|
ES2963910T3
(es)
*
|
2008-06-26 |
2024-04-03 |
Zevra Denmark As |
Uso de Hsp70 como regulador de la actividad enzimática
|
|
EP2323652A2
(en)
|
2008-08-06 |
2011-05-25 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
WO2010022461A1
(en)
|
2008-08-29 |
2010-03-04 |
Children, Youth And Women's Health Service |
Sulphated sugars to increase activity of sulphatases en lysosomal storage disorders
|
|
CA2736545A1
(en)
|
2008-09-29 |
2010-04-01 |
Vertex Pharmaceuticals Incorporated |
Dosage units of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
WO2010053655A2
(en)
|
2008-11-07 |
2010-05-14 |
University Of Kansas |
Therapeutic methods with withaferin a and analogs
|
|
EP2391229B1
(en)
|
2009-01-29 |
2015-07-15 |
Alfa Biogene International B.V. |
Functional food product comprising heat shock protein or a hydrolysate thereof from alfalfa
|
|
EP2218458A1
(en)
|
2009-02-13 |
2010-08-18 |
Fondazione Telethon |
Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
|
|
WO2010102988A1
(en)
|
2009-03-10 |
2010-09-16 |
Alfa Biogene International B.V. |
Skin care product
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
US8785168B2
(en)
|
2009-06-17 |
2014-07-22 |
Biomarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
MX2012001268A
(es)
|
2009-07-28 |
2012-09-12 |
Shire Human Genetic Therapies |
Composiciones y metodos para tratar enfermedad de gaucher.
|
|
US20120156180A1
(en)
|
2009-08-10 |
2012-06-21 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
|
|
US20110081428A1
(en)
|
2009-09-16 |
2011-04-07 |
The Buck Institute For Age Research |
Use of thioflavin-like compounds to increase life span and/or health span
|
|
US8609416B2
(en)
|
2009-12-18 |
2013-12-17 |
Ventria Bioscience |
Methods and compositions comprising heat shock proteins
|
|
US20120009125A1
(en)
*
|
2010-07-06 |
2012-01-12 |
Lombard Jay L |
Apoe4 and apoj biomarker-based prevention and treatment of dementia
|
|
WO2012012656A2
(en)
|
2010-07-21 |
2012-01-26 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
EP2646044B1
(en)
|
2010-11-30 |
2019-08-28 |
Orphazyme A/S |
Methods for increasing intracellular activity of hsp70
|
|
WO2013006076A1
(en)
|
2011-07-04 |
2013-01-10 |
New York University |
The use of intranasally administered hsp70 protein to treat neurodegenerative diseases
|
|
EP2831039A1
(en)
|
2012-03-28 |
2015-02-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
AU2013337354A1
(en)
*
|
2012-11-05 |
2015-05-21 |
Genzyme Corporation |
Compositions and methods for treating proteinopathies
|
|
JP6571527B2
(ja)
|
2012-11-21 |
2019-09-04 |
ウーハン ワイゼットワイ バイオファルマ カンパニー リミテッドＷｕｈａｎ Ｙｚｙ Ｂｉｏｐｈａｒｍａ Ｃｏ．， Ｌｔｄ． |
二重特異性抗体
|
|
WO2015119989A1
(en)
*
|
2014-02-04 |
2015-08-13 |
New York University |
Progranulin (pgrn) and its derivatives for diagnosis and treatment of lysosomal storage diseases
|
|
AU2015317447B2
(en)
|
2014-09-15 |
2021-02-25 |
Zevra Denmark A/S |
Arimoclomol formulation
|
|
BR112017007025A2
(pt)
*
|
2014-10-10 |
2017-12-12 |
Univ Virginia Commonwealth |
sulfatos de colesterol oxigenados para terapia de distúrbios causados por pelo menos um de atividade de leptina atenuada e um distúrbio de armazenamento de lipídio
|